ZA202201449B - Veterinary compositions for the prevention and/or treatment of cryptosporidiosis - Google Patents

Veterinary compositions for the prevention and/or treatment of cryptosporidiosis

Info

Publication number
ZA202201449B
ZA202201449B ZA2022/01449A ZA202201449A ZA202201449B ZA 202201449 B ZA202201449 B ZA 202201449B ZA 2022/01449 A ZA2022/01449 A ZA 2022/01449A ZA 202201449 A ZA202201449 A ZA 202201449A ZA 202201449 B ZA202201449 B ZA 202201449B
Authority
ZA
South Africa
Prior art keywords
cryptosporidiosis
prevention
treatment
veterinary compositions
veterinary
Prior art date
Application number
ZA2022/01449A
Inventor
Béatrice Besche
Catherine Jimenez
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Publication of ZA202201449B publication Critical patent/ZA202201449B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2022/01449A 2019-08-01 2022-02-01 Veterinary compositions for the prevention and/or treatment of cryptosporidiosis ZA202201449B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19305996 2019-08-01
PCT/EP2020/071631 WO2021019067A1 (en) 2019-08-01 2020-07-31 Veterinary compositions for the prevention and/or treatment of cryptosporidiosis

Publications (1)

Publication Number Publication Date
ZA202201449B true ZA202201449B (en) 2022-09-28

Family

ID=67659163

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2022/01449A ZA202201449B (en) 2019-08-01 2022-02-01 Veterinary compositions for the prevention and/or treatment of cryptosporidiosis

Country Status (10)

Country Link
EP (1) EP4007583A1 (en)
JP (1) JP2022542691A (en)
KR (1) KR20220041862A (en)
CN (1) CN114258302A (en)
AU (1) AU2020322102A1 (en)
BR (1) BR112022001759A2 (en)
CA (1) CA3148720A1 (en)
MX (1) MX2022001329A (en)
WO (1) WO2021019067A1 (en)
ZA (1) ZA202201449B (en)

Also Published As

Publication number Publication date
CN114258302A (en) 2022-03-29
EP4007583A1 (en) 2022-06-08
CA3148720A1 (en) 2021-02-04
MX2022001329A (en) 2022-03-04
JP2022542691A (en) 2022-10-06
WO2021019067A1 (en) 2021-02-04
KR20220041862A (en) 2022-04-01
AU2020322102A1 (en) 2022-03-03
BR112022001759A2 (en) 2022-04-12

Similar Documents

Publication Publication Date Title
EP3777888A4 (en) Pharmaceutical composition for treatment and/or prevention of cancer
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
EP3639833A4 (en) Agent for the prevention or treatment of fat-related diseases and/or inflammation
ZA202007055B (en) Compositions for the treatment of skin conditions
ZA202006610B (en) Compositions for the treatment of skin conditions
IL287796A (en) Compositions and methods for the treatment of atpase-mediated diseases
EP3935078A4 (en) Compositions and methods for the diagnosis and treatment of retinopathies
RS65256B1 (en) Use of nmn for the prevention and/or treatment of pain, and corresponding compositions
EP4171606A4 (en) Compositions and methods for the treatment of covid-19
IL272097A (en) Compounds for the prevention and treatment of medical disorders and uses thereof
IL282904A (en) Therapeutic microbiota for the treatment and/or prevention of dysbiosis
PT3810128T (en) Compositions for treating and/or preventing protein-aggregation diseases
EP3750529A4 (en) Composition for prevention and treatment of spinal cord injury
EP3534924A4 (en) Composition for the prevention and/or treatment of cardiovascular diseases
EP4041390A4 (en) Compositions and methods for the treatment or prevention of traumatic brain injury
ZA202201449B (en) Veterinary compositions for the prevention and/or treatment of cryptosporidiosis
IL276228A (en) Compounds and compositions for the treatment of pain
EP3811958A4 (en) Composition for the prevention and/or treatment of haemorrhoids
EP4034137A4 (en) Compositions and methods for the prevention and treatment of pancreatitis
IL271564A (en) Compositions for the prevention and treatment of acute renal injury
IL268860A (en) Granzyme b inhibitor compositions and methods for the prevention and/or treatment of skin blistering and/or peeling
LT3758799T (en) Composition for the prevention and treatment of skin damages caused by photo-exposure
EP3836949A4 (en) Compositions comprising sel1-derived peptides and methods of treatment/prevention of excess oxalate levels and associated conditions/diseases therewith
HUE065847T2 (en) Compositions for the prevention and treatment of cutaneous affections
GB2574944B (en) Methods and compositions for the treatment of pain and/or inflammation